- ►diabetesjournals.org KJ Williams, ML Liu, Y Zhu, X Xu, WR Davidson, P … - Diabetes, 2005 - Am Diabetes Assoc The basis for accelerated atherosclerosis in diabetes is unclear. Diabetes is associated with
loss of heparan sulfate (HS) from the liver, which may impede lipoprotein clearance and thereby
worsen atherosclerosis. To study hepatic HS loss in diabetes, we examined regulation of ... Cited by 19 - Related articles - All 5 versions
- ►nih.gov JM MacArthur, JR Bishop, KI Stanford, L … - Journal of Clinical …, 2007 - Am Soc Clin Investig We examined the role of hepatic heparan sulfate in triglyceride-rich lipoprotein metabolism by
inactivating the biosynthetic gene GlcNAc N-deacetylase/N-sulfotransferase 1 (Ndst1) in hepatocytes
using the Cre-loxP system, which resulted in an approximately 50% reduction in sulfation ... Cited by 63 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org [PDF] M Rodriguez-Lee, G Ostergren-Lunden, B … - … , and vascular biology, 2006 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Fatty Acids Cause Alterations of Human Arterial Smooth Cited by 16 - Related articles - All 7 versions
- ►oxfordjournals.org B Yard, Y Feng, H Keller, C Mall, F van der … - Nephrology Dialysis …, 2002 - ERA-EDTA Results. In each group of patients, 25 mM D-glucose significantly reduced the incorporation of
[ 3 H]glucosamine (P<0.01), but not [ 35 S]sulphate. The quantity of NDST 1 mRNA expression
did not differ between the four groups. In the non-diabetic group only, 25 mM D-glucose ... Cited by 6 - Related articles - BL Direct - All 4 versions
LR Tannock, A Chait - Front Biosci, 2004 - bioscience.org 1. Abstract 2. Introduction 2.1. Response to retention hypothesis 2.2. Composition of vascular
extracellular matrix 3. Lipoprotein Determinants of Retention 3.1. Proteoglycan binding site of
apo B100 3.2. Proteoglycan binding site of apo B48 3.3. Proteoglycan binding site of apo ... Cited by 17 - Related articles - View as HTML - All 3 versions
- ►ahajournals.org M Gustafsson, M Levin, K Skalen, J Perman, V … - Circulation …, 2007 - Am Heart Assoc Direct binding of apolipoprotein (apo)B-containing lipoproteins to proteoglycans is the initiating
event in atherosclerosis, but the processes involved at later stages of development are
unclear. Here, we investigated the importance of the apoB–proteoglycan interaction in the ... Cited by 18 - Related articles - All 5 versions
KJ Williams, JE Feig, EA Fisher - Nature Clinical Practice Cardiovascular …, 2008 - nature.com KJ Williams is Professor of Medicine, Professor of Biochemistry and Molecular Biology, and a
Member of the Center for Human Virology and Biodefense at Thomas Jefferson University,
Philadelphia, PA, USA. His research on cardiovascular disease focuses on how normal ... Cited by 20 - Related articles - BL Direct - All 5 versions
U Olsson, AC Egnell, MR Lee, GÖ Lundén, M … - Diabetes, 2001 - Am Diabetes Assoc Insulin resistance and type 2 diabetes are associated with elevated circulating levels of
insulin, nonesterified fatty acids (NEFAs), and lipoprotein remnants. Extracellular matrix proteoglycan
(PG) alterations are also common in macro- and microvascular complications of type 2 ... Cited by 22 - Related articles - BL Direct - All 5 versions
[CITATION] Classic Paper: The birth of proteoglycans: the nature of the link between protein …
